Generated by AI
Haleon Plc ADR is an American depositary receipt representing Haleon plc, a consumer healthcare company headquartered in Weybridge, United Kingdom. Haleon develops, manufactures, and markets a broad range of self-care products focused on everyday health needs, including oral health, pain relief, respiratory care, digestive health, and vitamins and supplements. Its portfolio serves consumers seeking non-prescription solutions for routine wellness and symptom management across North America, Europe, Latin America, and Asia Pacific. The company operates in the healthcare sector through well-known consumer brands that are distributed through pharmacies, grocery channels, mass retailers, and other consumer-facing outlets. Haleon Plc ADR provides U.S. investors access to a globally diversified consumer health business with exposure to demand for essential, repeat-purchase healthcare products.
WebsiteThe Heights
Weybridge, KT13 0NY
United Kingdom
The latest articles about HLN.
Haleon (LSE:HLN) is back on investor watchlists after fresh returns data showed the shares down about 4% over the past month and roughly 4% over the past 3 months. That shorter term weakness sits against a tougher backdrop, with Haleon’s share price return down 7.8% year to date and the 1 year total shareholder return slipping 7.5%, even though the 3 year total shareholder return remains positive at about 10%. Scan how Haleon compares to other defensive healthcare plays under pressure by...
Haleon has delivered a 10.0% share price gain over the past three years, yet the stock is still asking investors to judge whether that journey lines up with the cash it is expected to generate. The open question is whether the current valuation of Haleon stock can be explained by the stream of cash flows implied in its price today. That 10.0% return over three years puts real money on the line for anyone asking whether Haleon's current share price can be backed by the cash it is expected to...
Haleon has underperformed since its 2022 spin from GSK, delivering just over 6% annualized returns, including dividends. Read why HLN stock is a Buy.
Summary of Oct 29's posts. Generated by AI.
No summary yet.
Summary of Jun 7's posts. Generated by AI.
No summary yet.
Summary of Jun 7's posts. Generated by AI.
Investors talking about HLN also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.